BioSpace News Archive

Alex’s area of focus is on investments in General Atlantic’s technology sector, where he leads the thematic sourcing program for General Atlantic and co-heads its Emerging Growth Initiative.

Related patents granted in the United States, Japan, Australia, Mexico, China, Indonesia, South Korea and Russia; Patents pending in Brazil and other countries

PainShield Added to Federal Supply Schedule through Marathon Medical, Providing Opioid Alternative Pain Management System

Gregory Robinson, Ph.D., Appointed to Chief Scientific Officer Co-Founder Michael McKenna, M.D., Expands Role to Full-Time Chief Medical Officer

RADiant treatment system from Xstrahl, global leader in superficial radiotherapy devices to treat non-melanoma skin cancer and dermatological conditions.

New capital will allow Capstone to continue to grow its best-in-class platform in a fragmented sector

Combined Company Will Trade on the Nasdaq Capital Market under “DMTK”

Kowa Company Ltd. (Headquarters: Nagoya, Japan, President & CEO: Yoshihiro Miwa, hereafter referred to as “Kowa”) has been developing “Ripasudil Hydrochloride Hydrate” (hereafter referred to as “this Substance”), a Rho kinase inhibitor, for the indication of corneal endothelial diseases (Developmental code: K-321).

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for the Company’s investigational prophylactic vaccine for the prevention of respiratory syncytial virus (RSV)-mediated lower respiratory tract disease in adults aged 60 years or older.

Maverick Medical AI (“Maverick”) is pleased to announce that it has entered into a commercial agreement with US Health Systems (USHS), a leading health management company in partnership with Arizona Complete Health.